20-6084063-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_017671.5(FERMT1):​c.1695T>C​(p.Phe565Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.364 in 1,612,042 control chromosomes in the GnomAD database, including 110,378 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.37 ( 10836 hom., cov: 33)
Exomes 𝑓: 0.36 ( 99542 hom. )

Consequence

FERMT1
NM_017671.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.118

Publications

23 publications found
Variant links:
Genes affected
FERMT1 (HGNC:15889): (FERM domain containing kindlin 1) This gene encodes a member of the fermitin family, and contains a FERM domain and a pleckstrin homology domain. The encoded protein is involved in integrin signaling and linkage of the actin cytoskeleton to the extracellular matrix. Mutations in this gene have been linked to Kindler syndrome. [provided by RefSeq, Dec 2009]
FERMT1 Gene-Disease associations (from GenCC):
  • Kindler syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 20-6084063-A-G is Benign according to our data. Variant chr20-6084063-A-G is described in ClinVar as [Benign]. Clinvar id is 260868.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.118 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.601 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FERMT1NM_017671.5 linkc.1695T>C p.Phe565Phe synonymous_variant Exon 13 of 15 ENST00000217289.9 NP_060141.3 Q9BQL6-1Q54A15Q49AC8
FERMT1XM_024451935.2 linkc.1695T>C p.Phe565Phe synonymous_variant Exon 13 of 15 XP_024307703.1
FERMT1XM_047440259.1 linkc.1695T>C p.Phe565Phe synonymous_variant Exon 13 of 15 XP_047296215.1
FERMT1XM_047440260.1 linkc.1410T>C p.Phe470Phe synonymous_variant Exon 12 of 14 XP_047296216.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FERMT1ENST00000217289.9 linkc.1695T>C p.Phe565Phe synonymous_variant Exon 13 of 15 1 NM_017671.5 ENSP00000217289.4 Q9BQL6-1

Frequencies

GnomAD3 genomes
AF:
0.370
AC:
56313
AN:
152038
Hom.:
10824
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.351
Gnomad AMI
AF:
0.416
Gnomad AMR
AF:
0.456
Gnomad ASJ
AF:
0.371
Gnomad EAS
AF:
0.617
Gnomad SAS
AF:
0.283
Gnomad FIN
AF:
0.273
Gnomad MID
AF:
0.386
Gnomad NFE
AF:
0.365
Gnomad OTH
AF:
0.387
GnomAD2 exomes
AF:
0.376
AC:
94290
AN:
250470
AF XY:
0.367
show subpopulations
Gnomad AFR exome
AF:
0.342
Gnomad AMR exome
AF:
0.488
Gnomad ASJ exome
AF:
0.380
Gnomad EAS exome
AF:
0.630
Gnomad FIN exome
AF:
0.271
Gnomad NFE exome
AF:
0.355
Gnomad OTH exome
AF:
0.366
GnomAD4 exome
AF:
0.363
AC:
530625
AN:
1459886
Hom.:
99542
Cov.:
41
AF XY:
0.361
AC XY:
262202
AN XY:
726364
show subpopulations
African (AFR)
AF:
0.344
AC:
11518
AN:
33446
American (AMR)
AF:
0.482
AC:
21516
AN:
44620
Ashkenazi Jewish (ASJ)
AF:
0.373
AC:
9746
AN:
26128
East Asian (EAS)
AF:
0.636
AC:
25219
AN:
39662
South Asian (SAS)
AF:
0.275
AC:
23667
AN:
86180
European-Finnish (FIN)
AF:
0.274
AC:
14591
AN:
53344
Middle Eastern (MID)
AF:
0.372
AC:
2146
AN:
5764
European-Non Finnish (NFE)
AF:
0.360
AC:
399804
AN:
1110418
Other (OTH)
AF:
0.372
AC:
22418
AN:
60324
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.443
Heterozygous variant carriers
0
17946
35893
53839
71786
89732
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12820
25640
38460
51280
64100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.370
AC:
56353
AN:
152156
Hom.:
10836
Cov.:
33
AF XY:
0.370
AC XY:
27486
AN XY:
74380
show subpopulations
African (AFR)
AF:
0.350
AC:
14550
AN:
41516
American (AMR)
AF:
0.456
AC:
6969
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.371
AC:
1285
AN:
3468
East Asian (EAS)
AF:
0.619
AC:
3195
AN:
5164
South Asian (SAS)
AF:
0.281
AC:
1357
AN:
4830
European-Finnish (FIN)
AF:
0.273
AC:
2887
AN:
10578
Middle Eastern (MID)
AF:
0.388
AC:
114
AN:
294
European-Non Finnish (NFE)
AF:
0.365
AC:
24790
AN:
67998
Other (OTH)
AF:
0.393
AC:
827
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1836
3672
5509
7345
9181
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
534
1068
1602
2136
2670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.371
Hom.:
43373
Bravo
AF:
0.387
Asia WGS
AF:
0.445
AC:
1548
AN:
3478
EpiCase
AF:
0.372
EpiControl
AF:
0.363

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 72% of patients studied by a panel of primary immunodeficiencies. Number of patients: 63. Only high quality variants are reported. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Kindler syndrome Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.47
CADD
Benign
1.2
DANN
Benign
0.65
PhyloP100
0.12
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs753927; hg19: chr20-6064710; COSMIC: COSV54098214; API